Disease/Infection News

RSS

CN Bio awarded Innovate UK grant to develop single and multi-organ models for COVID-19 research

CN Bio today announced it has received a grant from Innovate UK to develop human-relevant MPS to advance investigations into SARS-CoV-2 infection.

From CN-Bio 2 Mar 2021

Experimental therapy delays viral rebound in SHIV-infected macaques

A recent preclinical study by U.S. Military HIV Research Program (MHRP) researchers showed that an experimental therapy combining a TLR7 agonist and two broadly neutralizing antibodies delayed viral rebound in SHIV-infected macaques after antiretroviral therapy (ART) interruption.

2 Mar 2021

Study: Public attitude toward COVID-19 and its treatments is more “infectious” than disease itself

Public attitude toward COVID-19 and its treatments is more "infectious" than the disease itself, according to a new Northwestern Medicine study using Artificial Intelligence (AI) to analyze tweets about the virus.

2 Mar 2021

Graphene oxide-silver nanoparticles shown to rapidly neutralize RNA viruses

While the vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are administered, and extensive research is conducted for targeted therapeutics to control the COVID-19 (coronavirus disease 2019), it is equally crucial to develop more novel, broad-spectrum antiviral compounds.

2 Mar 2021

COVID-19 virus could be transmitted through fecal-contaminated river water

Scientists have identified that the COVID-19 virus could be transmitted through faecal contaminated river water.

2 Mar 2021

Biological activity-based modeling offers a new approach for drug discovery

Assessing a drug compound by its activity, not simply its structure, is a new approach that could speed the search for COVID-19 therapies and reveal more potential therapies for other diseases.

2 Mar 2021

Study analyzes factors that make people susceptible to false information about health

A new study from University of Kansas journalism & mass communication researchers examines what influences people to be susceptible to false information about health and argues big tech companies have a responsibility to help prevent the spread of misleading and dangerous information.

2 Mar 2021

Researchers develop models aimed at ensuring corona safety during cruises

New research will enhance corona safety during cruises and help cruise lines again attract passengers onboard.

2 Mar 2021

Scientists modify existing SIR class pandemic prediction model

A painful tradeoff between a number of infected and negative economic impact must be considered before deciding on the lockdown strategy within a city. As national economies continue to crumble, citizens wonder whether their governments did a good job at regulating the lockdown measures.

2 Mar 2021

Study shows how SARS-CoV-2 affects cytokines compared to other respiratory viruses

Respiratory viruses such as SARS-CoV-2 (causing COVID-19) can often catalyze an overactive immune response that leads to a life-threatening cycle, known as a cytokine storm.

2 Mar 2021

Hydroxychloroquine should not be used to prevent COVID-19, says WHO expert panel

The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have covid-19, say a WHO Guideline Development Group (GDG) panel of international experts in The BMJ today.

2 Mar 2021

Study shows asthma mediator IL-13 prevents SARS-CoV-2 infection

In a paper published on the bioRxiv preprint server, researchers reported the results on whether IL-13 expression in asthma patients reduces their susceptibility to SARS-CoV-2 infection.

1 Mar 2021

Alcohol and tobacco sales nationwide rose in the early months of COVID-19

COVID-19 has taken a huge medical, emotional and economic toll on Americans. Now, new Keck Medicine of USC research shows that the pandemic may also have harmful indirect consequences.

1 Mar 2021

Scientists establish infection models for SARS-CoV-2 UK & South African variants

New research suggests Syrian golden hamsters could be a potentially useful preclinical model for testing vaccine immunity against the acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.17 and B.1.351 variant.

1 Mar 2021

Enduring antibody response observed after natural immunity and first Pfizer SARS-CoV-2 vaccine shot

Immunity gained after natural infection from the acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is boosted when people take the first Pfizer-BioNTech vaccine, according to a new study led by Iain C. Chapple from the University of Birmingham.

1 Mar 2021

Tier 3 interventions needed to contain SARS-CoV-2 transmission, especially with emergence of variants

Studies have shown that non-pharmaceutical interventions (NPIs) such as social distancing and partial lockdowns effectively contain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. However, because of these measures' huge economic and social cost, the UK introduced a less socially disruptive tier system. This system was aimed at providing a consistent set of control measures with geographic flexibility.

1 Mar 2021

Study: Repurposed arthritis drug did not improve outcomes of patients with severe COVID-19 pneumonia

In a study published online February 25, 2021 in The New England Journal of Medicine, a repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia.

1 Mar 2021

Study: Highly efficient and balanced immune response key to avoiding COVID-19 symptoms

By analyzing blood samples from individuals infected with SARS-CoV-2, researchers in Singapore have begun to unpack the different responses by the body's T cells that determine whether or not an individual develops COVID-19.

1 Mar 2021

Cellular maps capture COVID-19 pathogenesis in detail

Researchers in the United States and Finland have used tissues from people who died from coronavirus disease 2019 (COVID-19) to generate detailed cellular maps of the pathogenetic processes that occur within affected organs during severe disease.

1 Mar 2021

Study assesses causes of higher COVID-mortality among men

Researchers in the United States, Germany and Uganda have conducted a study showing that the factors responsible for a higher rate of coronavirus disease 2019 (COVID-19) mortality among males are specific to COVID-19 rather than related to men’s shorter life expectancy.

1 Mar 2021

Disease/Infection News

CN Bio awarded Innovate UK grant to develop single and multi-organ models for COVID-19 research

Experimental therapy delays viral rebound in SHIV-infected macaques

Study: Public attitude toward COVID-19 and its treatments is more “infectious” than disease itself

Graphene oxide-silver nanoparticles shown to rapidly neutralize RNA viruses

COVID-19 virus could be transmitted through fecal-contaminated river water

Biological activity-based modeling offers a new approach for drug discovery

Study analyzes factors that make people susceptible to false information about health

Researchers develop models aimed at ensuring corona safety during cruises

Scientists modify existing SIR class pandemic prediction model

Study shows how SARS-CoV-2 affects cytokines compared to other respiratory viruses

Hydroxychloroquine should not be used to prevent COVID-19, says WHO expert panel

Study shows asthma mediator IL-13 prevents SARS-CoV-2 infection

Alcohol and tobacco sales nationwide rose in the early months of COVID-19

Scientists establish infection models for SARS-CoV-2 UK & South African variants

Enduring antibody response observed after natural immunity and first Pfizer SARS-CoV-2 vaccine shot

Tier 3 interventions needed to contain SARS-CoV-2 transmission, especially with emergence of variants

Study: Repurposed arthritis drug did not improve outcomes of patients with severe COVID-19 pneumonia

Study: Highly efficient and balanced immune response key to avoiding COVID-19 symptoms

Cellular maps capture COVID-19 pathogenesis in detail

Study assesses causes of higher COVID-mortality among men

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News